Gamida Cell Ltd
NASDAQ:GMDA
Gamida Cell Ltd
NASDAQ:GMDA
Price:
0.0184 USD
2.22%
Market Closed
Updated:
May 2, 2024
Gamida Cell Ltd
Operating Income
|
Gamida Cell Ltd
Operating Income Peer Comparison
Comparables:
CLGN
KMDA
URGN
ENTX
B
BONS
Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Operating Income | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Gamida Cell Ltd
NASDAQ:GMDA
|
Operating Income
-$72.6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Collplant Biotechnologies Ltd
NASDAQ:CLGN
|
Operating Income
-$6.6m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
Kamada Ltd
NASDAQ:KMDA
|
Operating Income
$10.1m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
11%
|
|
|
Urogen Pharma Ltd
NASDAQ:URGN
|
Operating Income
-$65.5m
|
CAGR 3-Years
20%
|
CAGR 5-Years
3%
|
CAGR 10-Years
N/A
|
|
|
Entera Bio Ltd
NASDAQ:ENTX
|
Operating Income
-$8.9m
|
CAGR 3-Years
7%
|
CAGR 5-Years
4%
|
CAGR 10-Years
N/A
|
|
B
|
Bonus Biogroup Ltd
TASE:BONS
|
Operating Income
-₪32.9m
|
CAGR 3-Years
-22%
|
CAGR 5-Years
-14%
|
CAGR 10-Years
-13%
|
See Also
What is Gamida Cell Ltd's Operating Income?
Operating Income
-72.6m
USD
-72.6m
USD
Based on the financial report for Dec 31, 2023, Gamida Cell Ltd's Operating Income amounts to -72.6m USD.
What is Gamida Cell Ltd's Operating Income growth rate?
Operating Income CAGR 5Y
-17%
-17%
Over the last year, the Operating Income growth was 3%. The average annual Operating Income growth rates for Gamida Cell Ltd have been -6% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
